X-153872214-C-T

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_001278116.2(L1CAM):​c.338G>A​(p.Arg113His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000456 in 1,206,417 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R113C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000037 ( 0 hom., 0 hem., cov: 21)
Exomes 𝑓: 0.000046 ( 0 hom. 12 hem. )

Consequence

L1CAM
NM_001278116.2 missense

Scores

1
7
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.127

Publications

1 publications found
Variant links:
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
L1CAM Gene-Disease associations (from GenCC):
  • L1 syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • MASA syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • X-linked complicated corpus callosum dysgenesis
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • X-linked complicated spastic paraplegia type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.101777434).
BP6
Variant X-153872214-C-T is Benign according to our data. Variant chrX-153872214-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 458213.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0000367 (4/109077) while in subpopulation AMR AF = 0.000297 (3/10100). AF 95% confidence interval is 0.0000803. There are 0 homozygotes in GnomAd4. There are 0 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 12 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001278116.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
L1CAM
NM_001278116.2
MANE Select
c.338G>Ap.Arg113His
missense
Exon 5 of 29NP_001265045.1
L1CAM
NM_000425.5
c.338G>Ap.Arg113His
missense
Exon 4 of 28NP_000416.1
L1CAM
NM_024003.3
c.338G>Ap.Arg113His
missense
Exon 4 of 27NP_076493.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
L1CAM
ENST00000370060.7
TSL:5 MANE Select
c.338G>Ap.Arg113His
missense
Exon 5 of 29ENSP00000359077.1
L1CAM
ENST00000361699.8
TSL:1
c.338G>Ap.Arg113His
missense
Exon 4 of 27ENSP00000355380.4
L1CAM
ENST00000361981.7
TSL:1
c.323G>Ap.Arg108His
missense
Exon 3 of 26ENSP00000354712.3

Frequencies

GnomAD3 genomes
AF:
0.0000367
AC:
4
AN:
109077
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000297
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000191
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000213
AC:
39
AN:
183388
AF XY:
0.000162
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00117
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000625
Gnomad NFE exome
AF:
0.0000366
Gnomad OTH exome
AF:
0.000441
GnomAD4 exome
AF:
0.0000465
AC:
51
AN:
1097340
Hom.:
0
Cov.:
31
AF XY:
0.0000331
AC XY:
12
AN XY:
362718
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26393
American (AMR)
AF:
0.00108
AC:
38
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19382
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.0000370
AC:
2
AN:
54127
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40511
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4133
European-Non Finnish (NFE)
AF:
0.0000119
AC:
10
AN:
841318
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000367
AC:
4
AN:
109077
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
31441
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30015
American (AMR)
AF:
0.000297
AC:
3
AN:
10100
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2621
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3443
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2298
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5829
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000191
AC:
1
AN:
52427
Other (OTH)
AF:
0.00
AC:
0
AN:
1434
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000686
Hom.:
1
Bravo
AF:
0.000215
ExAC
AF:
0.000206
AC:
25

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

History of neurodevelopmental disorder Uncertain:1
Sep 16, 2016
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R113H variant (also known as c.338G>A), located in coding exon 4 of the L1CAM gene, results from a G to A substitution at nucleotide position 338. The arginine at codon 113 is replaced by histidine, an amino acid with highly similar properties. This variant co-segregated with disease in one family tested in our laboratory. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples with coverage at this position. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear.

Spastic paraplegia Benign:1
Oct 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

L1CAM-related disorder Benign:1
Apr 18, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.57
D
FATHMM_MKL
Benign
0.67
D
LIST_S2
Uncertain
0.94
D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.10
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
0.13
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.21
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.014
D
Polyphen
1.0
D
Vest4
0.42
MutPred
0.72
Loss of MoRF binding (P = 0.008)
MVP
0.65
MPC
1.7
ClinPred
0.11
T
GERP RS
5.0
Varity_R
0.72
gMVP
0.92
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781908326; hg19: chrX-153137669; COSMIC: COSV62827252; COSMIC: COSV62827252; API